Dissertation > Excellent graduate degree dissertation topics show

Clinical Study on Childhood Acute Lymphoblastic Leukemia by Stude-jude-05 Protocol

Author: ChuJinHua
Tutor: WangNingLing
School: Anhui Medical University,
Course: Pediatrics
Keywords: Childhood Acute lymphoblastic leukemia MICM classification Stude-jude-05 Protocol
CLC: R733.7
Type: Master's thesis
Year: 2011
Downloads: 22
Quote: 0
Read: Download Dissertation

Abstract


Background Acute lymphoblaslic leukemia(ALL) is the major malignant tumor in childhood,.Muhiagent chemotherapy has significantly improved survival for childhood ALL.We inducted Stude-jude-05 Protocol treatment the newly diagnosed patients with ALL since July 2007.Objective To collect the clinical and laboratory data of ALL patients and analysis the CR rate relapse rate,CNSL,treatment related events,Finally evaluating the Stude-jude-05 Protocol。Methods 62 children under 14 years old diagnosed with ALL were incruited in the study.The date of last follow—up was Des 2010.MICM and clinical risk classification were done and the chemotherapy regimen was used according to the Stude-jude-05 protoc01.Patients were stratified into the standard—riskgroup(LR),the rmedium—risk(MR),the high—riskgroup(HR), and the super-high-rish(SHR).Statistical analysisWas done by software SPSS 1 1.5for Windows.Results:1.62 childhoods with ALL were treated with the Stude-jude-05 protocol during June 2007 to December 2010. Of the 62 ALL patients,60(96.77%) achieved complete remission(CR).2.Relapse occurred in 13 of 62 patients(20.96%).10 patients had bone marrow relapse,2 patients had simple CNS relapse and 1 patients had testis combined with CNS replase.The relapse rate was 41.17%(7/17)in the HR and SHR,26.66(4/15)in the MR and 6.66%(2/30)in the SR.So,the relapse rate among the three risk groups show significant difference(P<0.05).3.Cox proportional hazard model analysis show that bone marrow response of D 19 and the clinical risk factor classification are independent prognostic indicators.4.Treatment-related death didn’t occurr .The major death was gave up the treatments when he relapsed.5.The measurement of MRD offers the promise of individualized,risk-stratified treatment.。6.The results indicated that the bone mass suppression is serious,resulting in infection. The drug related side effects could be controlled with the comprehensive prevention measures,

Related Dissertations

  1. The Expression and Preliminary Functional Research of Cyclin C in Childhood Acute Lymphoblastic Leukemia,R733.71
  2. The Differential Proteomics Analysis of Cells from Children with Acute Lympho Blastic Leukemia,R733.7
  3. Study on Abnormal Expression of the p73, DCC, nm23-H1, and E2A-PBX1 Genes in Childhood Acute Lymphoblastic Leukemia and Cell Lines,R733.71
  4. Prognostic Value of Detection of Lymphoblasts in the Period of Early Treatment in Childhood Acute Lymphoblastic Leukemia,R733.711
  5. Induction of Apoptosis by d-limonene is Mediated by Mitochondrial Death Pathway in Human Leukemia Cells,R733.7
  6. The Expression and Relationships of Bmi-1 and c-myc in Diffuse Large B-cell Lymphoma Tissues,R733.1
  7. Exploration of the Risk Factors and Assessment on the Clinical Staging Systems of Patients with Multiple Myeloma,R733.3
  8. Immunophenotype and Genetic Abnormalities Analysis in Multiple Myeloma,R733.3
  9. Effect of 5-Aza-CdR on the Biological Activity and Inhibitor of DNA Binding 4 (ID4) Gene Expression of Human Erythromyeloblastoid Leukemia Cell Line K562,R733.73
  10. Investigation of Clinial Death Associated Factors and Experimental Study in Children with Acute Leukemia,R733.7
  11. Multiple Myeloma Cells Derived Microvesicles: A Novel Efficient Way to Promote Myeloma Proliferation,R733.3
  12. Mutliple Myeloma-derived Microvesicles: A Novel Way to Promote Myeloma Angiogenesis,R733.3
  13. The Immuno-effects of DC-CIK Cells on Leukemia K562 Cell Lines,R733.7
  14. Experimental study of multiple myeloma thrombosis related factors,R733.3
  15. Effect of Inducing Apoptosis of Betulinic Acid on Human Multiple Myeloma Cell Line RPMI-8226,R733.3
  16. Multiple myeloma molecular cytogenetic techniques and cytogenetic abnormalities research,R733.3
  17. Investigation of Molecular Cytogenetics in Patients with Multiple Myeloma Using Interphase Fluorescence in Situ Hybridization,R733.3
  18. The Expression and Clinical Significance of Pi3k Signaling Pathway in Multiple Myeloma,R733.3
  19. Effects of Celastrol on the Proliferation and Apoptosis of Acute Myelogenous Leukemia Primary Cells,R733.7
  20. Bortezomib Effects Proliferation and Apoptosis on Osteoblast in Myeloma Bone Disease,R733.3
  21. The Expression and Significance of Medullary System Antigens in Multiple Myeloma,R733.3

CLC: > Medicine, health > Oncology > Hematopoietic and lymphoid neoplasms > Leukemia
© 2012 www.DissertationTopic.Net  Mobile